Drug addiction: a curable mental disorder?

被引:42
作者
Liu, Jian-feng [1 ]
Li, Jun-xu [1 ]
机构
[1] SUNY Buffalo, Dept Pharmacol & Toxicol, Univ Buffalo, Buffalo, NY 14203 USA
基金
美国国家卫生研究院;
关键词
drug addiction; pharmacological targets; behavioral treatment; brain stimulation; gene therapy; COGNITIVE-BEHAVIORAL THERAPY; COMPUTER-ASSISTED DELIVERY; N-ACETYLCYSTEINE; BRAIN-STIMULATION; SYNAPTIC PLASTICITY; COCAINE-SEEKING; GENE-EXPRESSION; NEURAL CIRCUITS; IMMUNE-SYSTEM; RECEPTOR;
D O I
10.1038/s41401-018-0180-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug addiction is a chronic, relapsing brain disorder. Multiple neural networks in the brain including the reward system (e.g., the mesocorticolimbic system), the anti-reward/stress system (e.g., the extended amygdala), and the central immune system, are involved in the development of drug addiction and relapse after withdrawal from drugs of abuse. Preclinical and clinical studies have demonstrated that it is promising to control drug addiction by pharmacologically targeting the addiction-related systems in the brain. Here we review the pharmacological targets within the dopamine system, glutamate system, trace amine system, antire-ward system, and central immune system, which are of clinical interests. Furthermore, we discuss other potential therapies, e.g., brain stimulation, behavioral treatments, and therapeutic gene modulation, which could be effective to treat drug addiction. We conclude that, although drug addiction is a complex disorder that involves complicated neural mechanisms and psychological processes, this mental disorder is treatable and may be curable by therapies such as gene modulation in the future.
引用
收藏
页码:1823 / 1829
页数:7
相关论文
共 109 条
  • [21] The Genetic Basis of Addictive Disorders
    Ducci, Francesca
    Goldman, David
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2012, 35 (02) : 495 - +
  • [22] Synaptic Dysfunction in Depression: Potential Therapeutic Targets
    Duman, Ronald S.
    Aghajanian, George K.
    [J]. SCIENCE, 2012, 338 (6103) : 68 - 72
  • [23] Gene therapy comes of age
    Dunbar, Cynthia E.
    High, Katherine A.
    Joung, J. Keith
    Kohn, Donald B.
    Ozawa, Keiya
    Sadelain, Michel
    [J]. SCIENCE, 2018, 359 (6372) : 175 - +
  • [24] Noninvasive brain stimulation treatments for addiction and major depression
    Dunlop, Katharine
    Hanlon, Colleen A.
    Downar, Jonathan
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2017, 1394 (01) : 31 - 54
  • [25] Effect of Varenicline on Smoking Cessation Through Smoking Reduction A Randomized Clinical Trial
    Ebbert, Jon O.
    Hughes, John R.
    West, Robert J.
    Rennard, Stephen I.
    Russ, Cristina
    Mcrae, Thomas D.
    Treadow, Joan
    Yu, Ching-Ray
    Dutro, Michael P.
    Park, Peter W.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (07): : 687 - 694
  • [26] Blockade of Toll-Like Receptor 4 Attenuates Morphine Tolerance and Facilitates the Pain Relieving Properties of Morphine
    Eidson, Lori N.
    Murphy, Anne Z.
    [J]. JOURNAL OF NEUROSCIENCE, 2013, 33 (40) : 15952 - 15963
  • [27] Opioid Use Disorder: A Desperate Need for Novel Treatments
    Fuehrlein, Brian S.
    Ross, David A.
    [J]. BIOLOGICAL PSYCHIATRY, 2017, 81 (07) : E43 - E45
  • [28] Ameliorating effect of histamine on impairment of cued fear extinction induced by morphine withdrawal in histidine decarboxylase gene knockout mice
    Gong, Ying-xia
    Shou, Wen-ting
    Feng, Bo
    Zhang, Wei-ping
    Wang, Hui-juan
    Ohtsu, Hiroshi
    Chen, Zhong
    [J]. ACTA PHARMACOLOGICA SINICA, 2010, 31 (11) : 1431 - 1437
  • [29] Trace amine-associated receptor 1 - Family archetype or iconoclast?
    Grandy, David K.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2007, 116 (03) : 355 - 390
  • [30] Affective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration
    Hamilton, Kathryn L.
    Harris, Andrew C.
    Gewirtz, Jonathan C.
    [J]. BRAIN RESEARCH, 2013, 1538 : 73 - 82